Tag: bispecific antibodies
Bispecific Antibody Evolution for Cancer Therapy: Advances from Merus, Adimab, Regeneron,...
The concept of using bispecific antibodies for tumor therapy has been developed more than 30 years ago with many initial struggles. However, new developments...
Merus Therpeutics: Seeking to Advance Immuno-Oncology
In Oncology, many new developments of the last decade have made it possible to treat cancers in ways that are better-targeted, more potent, and...
Sneaking Medicines Across the Blood-Brain Barrier
Research published in the November 2014 edition of The FASEB Journal, published by the Federation of the American Societies for Experimental Biology, suggests that a very small single domain antibody called FC5 has proven able to cross the blood-brain barrier (BBB). This opens the door to new treatments for a multitude of brain diseases.
